Myriad Genetics (MYGN)
(Real Time Quote from BATS)
$24.82 USD
+0.44 (1.81%)
Updated May 22, 2024 12:08 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.01 |
EPS Last Quarter | -0.01 |
Last EPS Surprise | 90.91% |
ABR | 2.45 |
Earnings ESP
|
-226.66% |
---|---|
Current Year | 0.03 |
Next Year | 0.25 |
EPS (TTM) | -0.08 |
P/E (F1) | 898.21 |
% EPS Growth Estimates | MYGN | IND | S&P |
---|---|---|---|
Current Qtr (06/2024) | 87.50 | 5,941.58 | 8.49 |
Next Qtr (09/2024) | 200.00 | 161.80 | 11.23 |
Current Year (12/2024) | 111.11 | 15.20 | 15.67 |
Next Year (12/2025) | 733.33 | 8.30 | 9.31 |
Past 5 Years | -191.50 | 1.00 | 8.10 |
Next 5 Years | 47.00 | 20.80 | NA |
PE | 898.21 | -3.70 | 21.54 |
PEG Ratio | 19.10 | -0.18 | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 205.21M | 208.65M | 832.34M | 899.97M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 207.44M | 211.60M | 836.70M | 912.20M |
Low Estimate | 203.52M | 206.50M | 825.00M | 889.68M |
Year ago Sales | 183.50M | 191.90M | 753.20M | 832.34M |
Year over Year Growth Est. | 11.83% | 8.73% | 10.51% | 8.13% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.01 | 0.03 | 0.03 | 0.25 |
# of Estimates | 7 | 5 | 7 | 7 |
Most Recent Consensus | 0.02 | 0.02 | 0.03 | 0.29 |
High Estimate | 0.02 | 0.06 | 0.04 | 0.37 |
Low Estimate | -0.05 | 0.01 | 0.02 | 0.03 |
Year ago EPS | -0.08 | -0.03 | -0.27 | 0.03 |
Year over Year Growth Est. | 87.50% | 200.00% | 111.11% | 733.32% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 2 | 1 |
Up Last 60 Days | 0 | 0 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 0 | 2 |
Down Last 60 Days | 1 | 1 | 0 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.01 | 0.03 | 0.03 | 0.25 |
7 Days Ago | -0.01 | 0.03 | 0.03 | 0.25 |
30 Days Ago | 0.00 | 0.03 | 0.02 | 0.29 |
60 Days Ago | 0.00 | 0.03 | 0.02 | 0.30 |
90 Days Ago | 0.01 | 0.00 | 0.02 | 0.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.02 | 0.01 | 0.03 | 0.20 |
Zacks Consensus Estimate | -0.01 | 0.03 | 0.03 | 0.25 |
Earnings ESP | -226.66% | -64.29% | 10.53% | -20.42% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.01 | 0.04 | -0.03 | -0.08 | NA |
Estimate | -0.11 | 0.02 | -0.08 | -0.10 | NA |
Difference | 0.10 | 0.02 | 0.05 | 0.02 | 0.05 |
Surprise | 90.91% | 100.00% | 62.50% | 20.00% | 68.35% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more